Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study

SUMMARY: The Forteo Patient Registry estimated the incidence of osteosarcoma in US patients treated with teriparatide and enrolled in the study between 2009 and 2019. No incident cases of osteosarcoma were identified among patients registered, and the crude incidence rate was 0 (95% confidence inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilsenan, A., Harris, D., Reynolds, M., McSorley, D., Midkiff, K., Jackson, L., Muldavin, B., Kellier-Steele, N., Andrews, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026426/
https://www.ncbi.nlm.nih.gov/pubmed/33151378
http://dx.doi.org/10.1007/s00198-020-05718-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026426/
https://www.ncbi.nlm.nih.gov/pubmed/33151378
http://dx.doi.org/10.1007/s00198-020-05718-0

Ejemplares similares